BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38904673)

  • 1. Vascular calcification in kidney stone formers: the impact of age and stone composition.
    Bnaya A; Kafka IZ; Barhoum H; Shavit L
    Urolithiasis; 2024 Jun; 52(1):97. PubMed ID: 38904673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between aortic calcification and the presence of kidney stones: calcium oxalate calculi in focus.
    Li B; Tang Y; Zhou L; Jin X; Liu Y; Li H; Huang Y; Wang K
    Int Urol Nephrol; 2022 Aug; 54(8):1915-1923. PubMed ID: 34846621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Disease and Kidney Stones: Abdominal Aortic Calcifications Are Associated with Low Urine pH and Hypocitraturia.
    Patel ND; Ward RD; Calle J; Remer EM; Monga M
    J Endourol; 2017 Sep; 31(9):956-961. PubMed ID: 28605936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
    Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
    Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stone composition and vascular calcifications in patients with nephrolithiasis.
    Ferraro PM; Marano R; Primiano A; Gervasoni J; Bargagli M; Rovere G; Bassi PF; Gambaro G
    J Nephrol; 2019 Aug; 32(4):589-594. PubMed ID: 31165423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interconversion of stone composition profiles from two recurrent stone episodes in stone formers.
    Zeng G; Zhao Z; Wu W; Ou L; Liang Y; Yuan J
    Clin Chem Lab Med; 2014 Jul; 52(7):1019-24. PubMed ID: 24633751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.
    Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M
    World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum biochemical metabolic panel with stone composition.
    Moreira DM; Friedlander JI; Carons A; Hartman C; Leavitt DA; Smith AD; Okeke Z
    Int J Urol; 2015 Feb; 22(2):195-9. PubMed ID: 25257446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stone composition as a function of age and sex.
    Lieske JC; Rule AD; Krambeck AE; Williams JC; Bergstralh EJ; Mehta RA; Moyer TP
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2141-6. PubMed ID: 25278549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and nephrolithiasis: a matched-case comparative study.
    Ganesan V; Chen WM; Jain R; De S; Monga M
    BJU Int; 2017 Jun; 119(6):919-925. PubMed ID: 28220601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results.
    Kustov AV; Strelnikov AI
    Urol J; 2018 May; 15(3):87-91. PubMed ID: 29277881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Factors Drive Staghorn
    Winoker JS; Bamberger JN; Chandhoke RA; Atallah W; Gupta M
    J Endourol; 2019 Nov; 33(11):954-959. PubMed ID: 31436119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.